Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Shutdown Bite Tightens At US FDA, But Gene Therapy To Get 50 More Reviewers

Jan 16 2019

• By Michael Cipriano

Decorin protein

Related Content

Gene Therapies: Accelerated Approval Open For Some, But Not All, Neurodegenerative Disease Treatments

Jan 08 2019

US FDA's Biologics Center Director Expects It Soon Will See 'Growth Spurt'

Jul 02 2018

Hemophilia Gene Therapy Studies Could Use Non-Inferiority Design, US FDA Suggests

Jul 16 2018

Shutdown Week Four: FDA Maintains Pre-Shutdown Output Pace In Some Cases

Jan 14 2019

Gene Therapies Need Long-Term Follow-Up Plan From Outset Or Risk Clinical Hold

Jul 12 2018

Drug Safety Announcement Blitz Highlights Gottlieb's PR Savvy As Shutdown Drags On

Jan 10 2019

Gottlieb On Gene Therapies: 'Very Seductive' To Think About Accelerated Approval Pathway

May 07 2018

CBER Implements Pre-Clinical Meeting Program For Biologics, Gene Therapy Sponsors

Jun 22 2018

Related Companies

Aimmune Therapeutics, Inc.

Additional Topics

United States Biologics Regenerative Medicine Regulation Drug Review Leadership FDA BioPharmaceutical

More from Cell & Gene Therapies

More from Advanced Technologies

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window